Category Archives: Technology

Lilly Increases Access to Clinical Trials Data

Eli Lilly and Company has announced it will begin sharing its clinical trial data with scientific researchers through www.clinicalstudydatarequest.com. The website, which houses data from several clinical trial sponsors, was created with support from PhRMA and EFPIA to increase access to and transparency of clinical trial results for researchers around the world.  
Also posted in E-Media, multimedia, R&D, Regulatory, Safety | Tagged , | Leave a comment

Lack of Multichannel Confidence: A Step on the Road to Digital Maturity

I’ve been lucky enough to get a sneak preview of Across Health’s 2014 Multichannel Barometer report. This is the sixth year the Belgium-based digital consultancy has conducted its Barometer survey and it’s interesting to look at the progress, or lack thereof, across the years. The data collected for last year’s survey led Across CEO Fonny […]
Also posted in E-Media, Europe, Guest Blog, Marketing, multimedia, Op-Ed | Tagged , , | Leave a comment

Fine-Tuning Your Multichannel Marketing Strategy

In today’s pharmaceutical industry, it seems there are nearly as many communication channels as there are instruments in the Philharmonic, and a similar level of coordination is needed to ensure multichannel success. Then, there’s the added challenge of managing interactions with today’s multifaceted customer, who could be a government agent; payer; physician (primary, specialist, or […]
Also posted in E-Media, Europe, Guest Blog, Marketing, multimedia, Strategy | Tagged , , | Leave a comment

Digital Technology: A Double-Edged Sword

Technology offers the promise of engaging patients on a level never seen before. The benefits of an engaged patient start with increased compliance—a great thing for pharmaceutical companies—and extend to a more active and empowered consumer of healthcare, and ultimately to better and more affordable outcomes. But technology is a double-edged sword. Its increasing complexity leads […]
Also posted in E-Media, Marketing, multimedia, social media | Tagged | Leave a comment

Paying for the Future of Medicine

Is the hallmark of innovation higher drug prices? The three leading justifications for sticker-shocking drug prices in the US, from the biopharma perspective, are: 1) it costs a lot to bring a drug to market;* 2) drugs – even very expensive ones – are cheaper in the long run since they prevent complications, hospitalizations and […]
Also posted in Biotech, FDA, healthcare, leadership, Manufacturing, Market Access, pricing, R&D, Regulatory | Tagged , , , , , , | 1 Comment
  • Categories

  • Meta